Bile Acid Activated Cell Signaling in the Liver and Nutrition
胆汁酸激活肝脏和营养中的细胞信号传导
基本信息
- 批准号:7629638
- 负责人:
- 金额:$ 28.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-21 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:ADP ribosylationAKT Signaling PathwayApoptosisBile AcidsBile fluidCYP7A1 geneCYP8B1 geneCell physiologyCeramidesCholestasisCholesterolChronicD CellsDataEGFR geneEndosomesEpithelial CellsExcisionFat-Soluble VitaminFistulaG Protein-Coupled Receptor GenesG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGallbladderGenesGenus ColaGrantHepatocyteIn VitroInsulinInsulin ReceptorIntestinesIntravenous infusion proceduresLipidsLipoproteinsLiverMAPK8 geneMessenger RNAModelingMolecularNecrosisNuclear ReceptorsPathway interactionsPertussis ToxinPhospholipidsProcessProtein Kinase CProteinsProto-Oncogene Proteins c-aktPublicationsRattusReceptor CellReportingResearch PersonnelRodentSignal PathwaySignal TransductionSignaling MoleculeSmall IntestinesSolutionsSpecificitySphingosineSteroidsStreamVitamin Dacidic sphingomyelinasebile saltscarcinogenesisceramide 1-phosphatecholangiocytecholesterol absorptioncholesterol controlcolon carcinogenesisgastrointestinal systemglucose metabolismin vivoinhibitor/antagonistinsightlipoprotein cholesterolliver metabolismmouse modelnutritionprogramspromoterreceptorsphingosine 1-phosphate
项目摘要
DESCRIPTION (provided by applicant): Bile acids are steroid molecules that are synthesized from cholesterol in the liver hepatocytes. Their synthesis represents a major excretory pathway for removal of cholesterol from the body. Recent studies show that bile acids also function as powerful regulatory molecules helping to coordinately control cholesterol, lipoprotein, and glucose metabolism in the liver. Bile acids are able to regulate the expression of numerous genes and activities of proteins through 2 distinct, yet highly coordinated cellular mechanisms. They can activate specific nuclear receptors (i.e. FXR, PXR, Vitamin D) and cell signaling pathways (i.e. JNK1/2, ERK1/2, AKT, protein kinase C). Each bile acid appears to show some degree of specificity as to which nuclear receptor and cell signaling pathway that it activates, suggesting that the bile acid pool composition may be an important regulator of liver metabolism. The specific aims of the current grant renewal application are: 1) Determine the identity of the G protein coupled receptor(s) (GPCR), which transduces conjugated bile acid signaling in primary hepatocytes via ERBB1 and the insulin receptor, to ERK1/2 and AKT pathways. Determine the molecular mechanism(s) by which the pertussis toxin sensitive GPCR signal causes activation of ERBB1 and the insulin receptor in primary hepatocytes. 2) Determine the mechanism(s) of activation of the JNK1/2 pathway by bile acids in primary rodent hepatocytes and in vivo. Determine how different bile acids activate acidic sphingomyelinase (ASM) in vitro. 3). Characterize the activation of the JNK1/2, ERK1/2 and AKT signaling pathways by different bile acids in the chronic bile fistula rat and mouse models. Determine the effects of different bile acid infusion (IV and ID) on the activation of cell signaling pathways, levels of selected lipid signaling molecules, and mRNA levels of key genes involved in cholesterol and glucose metabolism.
描述(由申请人提供):胆汁酸是由肝脏肝细胞中的胆固醇合成的类固醇分子。它们的合成代表了从体内清除胆固醇的主要排泄途径。最近的研究表明,胆汁酸还可以作为强大的调节分子,帮助协调控制肝脏中的胆固醇、脂蛋白和葡萄糖代谢。胆汁酸能够通过两种不同但高度协调的细胞机制调节众多基因的表达和蛋白质的活性。它们可以激活特定的核受体(即 FXR、PXR、维生素 D)和细胞信号传导通路(即 JNK1/2、ERK1/2、AKT、蛋白激酶 C)。每种胆汁酸似乎对其激活的核受体和细胞信号传导途径表现出一定程度的特异性,这表明胆汁酸库成分可能是肝脏代谢的重要调节剂。当前拨款续签申请的具体目标是: 1) 确定 G 蛋白偶联受体 (GPCR) 的身份,该受体通过 ERBB1 和胰岛素受体将原代肝细胞中的结合胆汁酸信号传导至 ERK1/2 和AKT 途径。确定百日咳毒素敏感 GPCR 信号引起原代肝细胞中 ERBB1 和胰岛素受体激活的分子机制。 2)确定原代啮齿动物肝细胞和体内胆汁酸激活JNK1/2途径的机制。确定不同胆汁酸如何在体外激活酸性鞘磷脂酶 (ASM)。 3)。表征慢性胆瘘大鼠和小鼠模型中不同胆汁酸对 JNK1/2、ERK1/2 和 AKT 信号通路的激活。确定不同胆汁酸输注(IV 和 ID)对细胞信号通路激活、选定脂质信号分子水平以及参与胆固醇和葡萄糖代谢的关键基因 mRNA 水平的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILLIP B HYLEMON其他文献
PHILLIP B HYLEMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILLIP B HYLEMON', 18)}}的其他基金
LncRNA H19 in Cholestatic Liver Diseases
LncRNA H19 在胆汁淤积性肝病中的作用
- 批准号:
10202570 - 财政年份:2018
- 资助金额:
$ 28.64万 - 项目类别:
LncRNA H19 in Cholestatic Liver Diseases
LncRNA H19 在胆汁淤积性肝病中的作用
- 批准号:
10909545 - 财政年份:2018
- 资助金额:
$ 28.64万 - 项目类别:
LncRNA H19 in Cholestatic Liver Diseases
LncRNA H19 在胆汁淤积性肝病中的作用
- 批准号:
9750721 - 财政年份:2018
- 资助金额:
$ 28.64万 - 项目类别:
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis
胆汁酸和 1-磷酸鞘氨醇受体介导的胆汁淤积信号传导
- 批准号:
9024718 - 财政年份:2015
- 资助金额:
$ 28.64万 - 项目类别:
Role of Bile Acids and Gut Bacteria in GI Diseases
胆汁酸和肠道细菌在胃肠道疾病中的作用
- 批准号:
8698288 - 财政年份:2012
- 资助金额:
$ 28.64万 - 项目类别:
Role of Bile Acids and Gut Bacteria in GI Diseases
胆汁酸和肠道细菌在胃肠道疾病中的作用
- 批准号:
8536579 - 财政年份:2012
- 资助金额:
$ 28.64万 - 项目类别:
Bile Acids and Clostridium scindens Inhibit C. difficile: Role of Secreted Antibacterial Compounds
胆汁酸和梭菌抑制艰难梭菌:分泌的抗菌化合物的作用
- 批准号:
9233344 - 财政年份:2012
- 资助金额:
$ 28.64万 - 项目类别:
Role of Bile Acids and Gut Bacteria in GI Diseases
胆汁酸和肠道细菌在胃肠道疾病中的作用
- 批准号:
8324091 - 财政年份:2012
- 资助金额:
$ 28.64万 - 项目类别:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
HIV 蛋白酶抑制剂和肝脂质失调
- 批准号:
7035831 - 财政年份:2004
- 资助金额:
$ 28.64万 - 项目类别:
相似国自然基金
归元剔络养血方通过Akt泛素化激活PI3K/Akt信号转导通路抑制视网膜神经节细胞凋亡的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于lncRNA调控的PI3K-AKT-mTOR信号通路探讨肺维康颗粒改善肺纤维化中M2型肺泡巨噬细胞凋亡抵抗的机制
- 批准号:82104799
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于PI3K/Akt/NF-κB信号通路的炎症-凋亡角度探讨瑶医油针对KOA模型大鼠软骨细胞的保护机制
- 批准号:82160949
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
新城疫病毒劫持AKT/mTOR信号途径调控自噬和凋亡交互对话的机制研究
- 批准号:31902251
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
弓形虫exosomes调控PI3K/Akt与MAPK信号通路诱导肿瘤细胞凋亡的机制研究
- 批准号:81971960
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Targeting Rheostatic Mechanisms of Melanoma Progression
针对黑色素瘤进展的变阻机制
- 批准号:
10441460 - 财政年份:2020
- 资助金额:
$ 28.64万 - 项目类别:
Targeting Rheostatic Mechanisms of Melanoma Progression
针对黑色素瘤进展的变阻机制
- 批准号:
10653021 - 财政年份:2020
- 资助金额:
$ 28.64万 - 项目类别:
Developing diagnostic and therapeutic stem cells for cancer therapy
开发用于癌症治疗的诊断和治疗干细胞
- 批准号:
8211001 - 财政年份:2010
- 资助金额:
$ 28.64万 - 项目类别:
Developing diagnostic and therapeutic stem cells for cancer therapy
开发用于癌症治疗的诊断和治疗干细胞
- 批准号:
8433259 - 财政年份:2010
- 资助金额:
$ 28.64万 - 项目类别:
Developing diagnostic and therapeutic stem cells for cancer therapy
开发用于癌症治疗的诊断和治疗干细胞
- 批准号:
8048074 - 财政年份:2010
- 资助金额:
$ 28.64万 - 项目类别: